Expectations trend
FY2028 · fiscal year ending 2028-08-01 · fmp
United Natural Foods Inc (UNFI)
NYSEConsumer StaplesFood DistributionSnapshot 2026-11-05
$46.01-4.72%
Close 2026-11-05 · 1-day change
NYSEConsumer StaplesFood DistributionSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.06 → 4.06 EPS · FY ending Aug 1, 2028 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for UNFI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Operating expenses near $954 million in 2026-Q2 | It aims to keep expenses near $954 million in 2026-Q2. | Intact | Operating expenses rise above $1.0 billion in 2026-Q2 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-08-01 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
UNFI is an operational recovery story in food distribution, with a sector tailwind and improving recent performance. The long-term thesis is intact and the signal has shifted from mixed to mildly favorable, but the company remains loss-making and management execution is uneven.
The valuation is expensive versus peers, with a 1.07 premium, while the expectations gap is negative, suggesting expectations are not fully aligned with the valuation. The evidence labels the pricing as justified and fragility as low, but it does not specify what earnings assumptions the market is using.
Near-term results have been strong, including a recent earnings beat, and company momentum improved. Management reports better service measures and lower debt, but operating expenses rose from the second to the third quarter, while sales eased; expense reduction and commercial progress remain limited. Near-term miss risk is described as low, though the industry has a high miss rate and UNFI has a deep miss in its recent history.
The multi-year case depends on network changes reducing costs while service improvements and newly onboarded business support revenue growth. In the near term, a guidance cut or further weakening in jobs could weigh on the business outlook, while continued earnings strength and higher guidance from sector peers would support the sector backdrop.
For the next 1 to 3 years, UNFI has improving momentum and a stronger balance sheet, but its loss-making profile, expensive relative valuation, and unfinished cost work keep the thesis dependent on execution. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in United Natural Foods Inc's published investment case. The stated target is ~1.0 USD_PER_SHARE. |
| Broken |
| EPS falls below $0.9 in fiscal Q4 2026 |
Diluted EPS: $0.56 per share FY2026-Q4; GAAP. Published target: ~1.0 USD_PER_SHARE. Same fiscal period as the stored target. Sep 14, 20260.56 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Free cash flow at least $300 million in fiscal 2026 | The company plans free cash flow of at least $300 million in fiscal 2026. | Broken | Free cash flow falls below $200 million in fiscal 2026 | Free cash flow: $80M FY2026-Q4; GAAP. Published target: >=300000000 USD. Same fiscal period as the stored target. Sep 14, 202680,000,000 USD · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue near $31.8 billion in fiscal 2026 | Revenue is expected around $31.8 billion in fiscal 2026. | Broken | Revenue falls below $31.6 billion in fiscal 2026 | Revenue: $7.642B FY2026-Q4; GAAP. Published target: ~31.8 USD_BILLIONS. Same fiscal period as the stored target. Sep 14, 20267,642,000,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.00 → $4.06 · observed estimates
$32.34B → $32.35B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-09-09 | $4.00 | $32,339,648,241 | 4 / 6 |
| 2026-09-10 | $4.07 | $32,278,536,757 | 3 / 7 |
| 2026-09-11 | $4.06 | $32,279,294,663 | 3 / 7 |
| 2026-09-12 | $4.06 | $32,279,294,663 | 3 / 7 |
| 2026-09-13 | $4.06 | $32,279,294,663 | 3 / 8 |
| 2026-09-14 | $4.06 | $32,279,294,663 | 3 / 8 |
| 2026-09-15 | $4.06 | $32,279,294,663 | 3 / 8 |
| 2026-09-16 | $4.06 | $32,279,294,663 | 3 / 8 |
| 2026-09-17 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-09-18 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-09-19 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-09-20 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-09-21 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-09-22 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-09-23 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-09-24 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-09-25 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-09-26 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-09-27 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-09-28 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-09-29 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-09-30 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-01 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-02 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-03 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-04 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-05 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-06 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-07 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-08 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-09 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-10 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-11 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-12 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-13 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-14 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-15 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-16 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-17 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-18 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-19 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-20 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-21 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-22 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-23 | $4.06 | $32,279,294,663 | 3 / 5 |
| 2026-10-24 | $4.06 | $32,351,789,144 | 3 / 5 |
| 2026-10-25 | $4.06 | $32,351,789,144 | 3 / 5 |
| 2026-10-26 | $4.06 | $32,351,789,144 | 3 / 5 |
| 2026-10-27 | $4.06 | $32,351,789,144 | 3 / 5 |
| 2026-10-28 | $4.06 | $32,351,789,144 | 3 / 5 |
| 2026-10-29 | $4.06 | $32,351,789,144 | 3 / 5 |
| 2026-10-30 | $4.06 | $32,351,789,144 | 3 / 5 |
| 2026-10-31 | $4.06 | $32,351,789,144 | 3 / 5 |
| 2026-11-01 | $4.06 | $32,351,789,144 | 3 / 5 |
| 2026-11-02 | $4.06 | $32,351,789,144 | 3 / 5 |
| 2026-11-03 | $4.06 | $32,351,789,144 | 3 / 5 |
| 2026-11-04 | $4.06 | $32,351,789,144 | 3 / 5 |
| 2026-11-05 | $4.06 | $32,351,789,144 | 3 / 5 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 7 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Dec 1, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.